| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
78.48(M) |
| Last
Volume: |
667,553 |
Avg
Vol: |
3,188,039 |
| 52
Week Range: |
$0.131 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Van Ness Kenneth |
CEO & President |
• • • |
2009-09-21 |
4 |
S |
$0.64 |
$5,696 |
I/I |
(8,900) |
2,027,559 |
|
- |
|
| Van Ness Kenneth |
CEO & President |
• • • |
2009-09-18 |
4 |
S |
$0.57 |
$593 |
I/I |
(1,041) |
2,036,459 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2009-07-01 |
4 |
B |
$0.50 |
$303,200 |
D/D |
606,400 |
606,400 |
2.39 |
- |
|
| Utek Corp |
10% Owner |
– – • |
2009-06-25 |
4 |
B |
$0.62 |
$1,460,808 |
D/D |
2,356,142 |
2,356,142 |
2.45 |
- |
|
| Utek Corp |
10% Owner |
– – • |
2009-06-25 |
4 |
S |
$23.56 |
$2,356,000 |
D/D |
(100,000) |
0 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-06-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
69,100 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-06-11 |
5 |
S |
$0.60 |
$960 |
I/I |
(1,600) |
233,409 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-22 |
5 |
S |
$0.67 |
$1,675 |
I/I |
(2,500) |
235,009 |
|
- |
|
| Van Ness Kenneth |
CEO & President |
• • • |
2009-05-22 |
4 |
S |
$0.80 |
$2,000 |
I/I |
(2,500) |
2,037,500 |
|
- |
|
| Allen Allen D |
Chief Executive Officer |
• • • |
2009-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
1,698,515 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-19 |
5 |
S |
$0.70 |
$7,000 |
I/I |
(10,000) |
237,509 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-18 |
5 |
S |
$0.50 |
$40,000 |
D/D |
(80,000) |
99,100 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
70,000 |
179,100 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-14 |
5 |
B |
$0.70 |
$140 |
I/I |
200 |
247,509 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-13 |
5 |
B |
$0.65 |
$65 |
I/I |
100 |
247,309 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-13 |
5 |
S |
$0.55 |
$5,275 |
I/I |
(9,590) |
247,209 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-07 |
5 |
B |
$0.75 |
$75 |
I/I |
100 |
256,799 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-05-07 |
5 |
S |
$0.56 |
$4,365 |
I/I |
(7,775) |
256,699 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-04-22 |
5 |
B |
$0.55 |
$385 |
I/I |
700 |
265,424 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-04-13 |
5 |
B |
$0.55 |
$55 |
I/I |
100 |
264,724 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-03-23 |
5 |
B |
$0.55 |
$110 |
I/I |
200 |
264,624 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-03-18 |
5 |
B |
$0.52 |
$52 |
I/I |
100 |
264,424 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-03-10 |
5 |
B |
$0.47 |
$189 |
I/I |
400 |
264,324 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-03-05 |
5 |
B |
$0.46 |
$115 |
I/I |
250 |
263,924 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2009-03-02 |
5 |
A |
$0.00 |
$0 |
D/D |
150,000 |
330,000 |
|
- |
|
381 Records found
|
|
Page 12 of 16 |
|
|
